IRIDEX Corporation is an ophthalmic medical technology company. It develops and commercializes products and procedures used to treat sight-threatening eye conditions, including glaucoma and retinal diseases. Its MicroPulse Technology and Endpoint Management Technology are used for the treatment of glaucoma and retina disorders. Its laser consoles product consists of Glaucoma, Medical Retina and Surgical Retina. Its glaucoma console line is the Cyclo G6 laser system with MicroPulse technology. Its surgical-retina product line includes its OcuLight TX and OcuLight SLx laser photocoagulation systems. Its medical-retina product line includes its portable IQ 532 and IQ 577 laser systems. Its laser probes products include Glaucoma and Surgical Retina. Probes used in its glaucoma product line include its patented single-use delivery devices-MicroPulse P3, G-Probe, and G-Probe Illuminate. Probes used in its surgical retina product line include its family of single-use EndoProbe handpieces.
Símbolo de cotizaciónIRIX
Nombre de la empresaIRIDEX Corp
Fecha de salida a bolsaFeb 16, 1996
Director ejecutivoMr. Patrick Mercer
Número de empleados93
Tipo de seguridadOrdinary Share
Fin del año fiscalFeb 16
Dirección1212 Terra Bella Ave
CiudadMOUNTAIN VIEW
Bolsa de valoresNASDAQ Capital Market Consolidated
PaísUnited States of America
Código postal94043
Teléfono16509404700
Sitio Webhttps://www.iridex.com/
Símbolo de cotizaciónIRIX
Fecha de salida a bolsaFeb 16, 1996
Director ejecutivoMr. Patrick Mercer
Un total de
0.00
USD se ha distribuido en dividendos durante los últimos 5 años.

Sin datos